We will be closed on Thanksgiving, November 26, 2020. We will be open on November 27, 2020.

product_peanut

How to order if you are a Patient: Thank you for your interest in our testing. Since all our testing must be ordered by a licensed health care practitioner, please have your current healthcare provider contact us so we can set them up with a Vibrant account.

How to order if you are a Provider: If you are a current Vibrant client, please contact support@vibrant-wellness.com or call your local Territory Sales Manager.

If you don’t have an account with Vibrant Wellness, please fill out a Client Application form to get started.

Peanut Zoomer

An innovative tool that measures IgG & IgA antibodies to peanut antigens.

Peanut sensitivity is often confused with peanut allergy. Unlike peanut allergy (which produces IgE antibodies), an individual produces IgG and IgA antibodies against peanut antigens in peanut sensitivity. Peanut sensitivity symptoms, like all other food sensitivity symptoms, are often delayed (takes hours to days), hence diagnosis of the exact sensitivity is nearly impossible and often misdiagnosed.

Peanut sensitivity is rarely outgrown with age. The best solution to reduce peanut-related incidences is to avoid peanut-containing food. But, it is highly unfeasible to completely avoid peanut containing foods, since most processed foods use peanuts as a food ingredient. Hence, there is a high possibility that you may get accidental exposure anytime you eat from a restaurant. Peanut sensitivity is not life-threatening like peanut allergy, but can develop into allergy and other future health problems if not diagnosed early. Also, early detection of peanut sensitivity will help to identify a proper individualized management plan and enable confidence in dietary and social activities.

Not Available in New York state
Only healthcare providers licensed in their state may order laboratory testing.

Major Antigens

  • Ara h 1 (Conarachin)
  • Ara h 2 (Conglutin 7)
  • Ara h 3
  • Ara h 6 (Conglutin 8)

Minor Antigens

  • Ara h 5(Profilin)
  • Ara h 7
  • Ara h 8 & isoform
  • Ara h 9
  • Ara h 10 (Oleosin 1)
  • Ara h 11(Oleosin 2)
  • Ara h 12(Defensin 1)
  • Ara h 13 & isoforms(Defensin 2 & Defensin 3)
  • Glycinin
  • Arachin
  • Oleosin Variant A
  • Oleosin variant B

Symptoms and Risk Factors of Peanut Sensitivity:

  • Headache – especially migraine
  • Nausea
  • Asthma
  • Fatigue and tiredness
  • Hyperactivity
  • Stomach pain and abdominal cramps
  • Stomach pain and abdominal cramps
  • Skin rashes (redness and itchiness)
  • Vomiting
  • Diarrhea
  • Age
  • Other sensitivities and allergies
  • Other sensitivities and allergies
  • Family history of sensitivities and allergies
  • Eczema

Citations/Sources

  • Husain Z, Schwartz RA. Peanut allergy: An increasingly common life-threatening disorder. Journal of the American Academy of Dermatology. 2012; 66: 136-143.
  • Lavine E. Blood testing for sensitivity, allergy or intolerance to food. Canadian Medical Association Journal. 2012; 184(6): 666-668.
  • Bush RK, Taylor SL, Nordlee JA. Peanut sensitivity.Allergy proceedings : the official journal of regional and state allergy societies 1989; 10: 261-264
  • Iqbal A, Shah F, Hamayun M, et al. Allergens of Arachishypogaea and the effect of processing on their detection by ELISA. Food & Nutrition Research. 2016; 60: 103402.
  • Maleki SJ, Kopper RA, Shin DS.Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. The Journal of Immunology. 2000;164:5844-5849.
  • Pomes A, Butts C. L, Chapman MD. Quantification of Ara h 1 in peanuts: why roasting makes a difference. Clinical & Experimental Allergy. 2006; 36: 824-830.
  • Maloney JM, Chapman MD, Sicherer SH. Peanut allergen exposure through saliva: assessment
    and interventions to reduce exposure. The Journal of Allergy Clinical Immunology. 2006;118(3):719-24.
  • Beyer K, Morrowa E, Li XM, Bardina L, et al. Effects of cooking methods on peanut allergenicity. A.
    Journal of Allergy and Clinical Immunology. 2001; 107(06): 1077-1081.
  • Jain, A. Cloning and structural analysis of a cDNA clone encoding glycinin (Gly-1) seed storage
    protein of peanut. Electronic Journal of Biotechnology. 2004: 12; 715 12.
  • Breiteneder H, Radauer CA. A classification of plant food allergens. Journal of Allergy
    and Clinical Immunology 2004; 113: 821-830.
  • Zhuang Y, Dreskin SC. Redefining the major peanut allergens. Immunologic research. 2013; 55(0):
    125-134. Costa J, Villa C, Fernandes TJR. Peanut Allergy: Clinical Relevance and Allergen
    Characterization. In: Rahman AMA. Food Allergy: Methods of Detection and Clinical Studies. Boca
    Raton, FL:CRC Press;2017.
  • Allegome database. Available at: http://www.allergome.org/index.php Uniport database. Available at:http://www.uniprot.org/uniprot
  • Schwager C, Kull S, Krause S, Schocker F, Petersen A, Becker WM, Jappe U. Development of a novel strategyto isolate lipophilic allergens (oleosins) from peanuts. PLoS One. 2015 Apr 10;10(4)

Recommended Tests to Consider

Wheat Zoomer
Sidebar_dairy
Dairy Zoomer
Lectin Zoomer

Regulatory Statement

Vibrant testing does not demonstrate absolute positive and negative predictive values for any disease state or condition. Its clinical utility has not been fully established. Vibrant validates the accuracy and precision of the testing but not of its clinical or diagnostic value. So these tests are for wellness and informational purpose only. Vibrant is actively doing clinical research on these samples, de-identified from patients under an IRB and will make research publications towards the same as and when the clinical utility is well established. These tests have been laboratory developed and their performance characteristics determined by Vibrant America LLC, a CLIA-certified laboratory performing the test CLIA#:05D2078809. The test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). Although FDA does not currently clear or approve laboratory-developed tests in the U.S., certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. The general wellness test intended uses relate to sustaining or offering general improvement to functions associated with a general state of health while making reference to diseases or conditions. Content provided for informational purposes only and should not be construed as medical advice. Content provided to help you make a healthy lifestyle, dietary, and treatment choices in consultation with your healthcare provider. It is intended to be used as a tool to encourage a general state of health and well-being. Please consult with your healthcare practitioner for diagnosis and treatment considerations. The Vibrant Wellness platform provides tools for you to track and analyze your general wellness profile.